1. Home
  2. SLRX vs ATXG Comparison

SLRX vs ATXG Comparison

Compare SLRX & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • ATXG
  • Stock Information
  • Founded
  • SLRX N/A
  • ATXG 2014
  • Country
  • SLRX United States
  • ATXG China
  • Employees
  • SLRX N/A
  • ATXG N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • ATXG Professional Services
  • Sector
  • SLRX Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • SLRX Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • SLRX 3.6M
  • ATXG 3.8M
  • IPO Year
  • SLRX N/A
  • ATXG N/A
  • Fundamental
  • Price
  • SLRX $4.18
  • ATXG $1.02
  • Analyst Decision
  • SLRX
  • ATXG
  • Analyst Count
  • SLRX 0
  • ATXG 0
  • Target Price
  • SLRX N/A
  • ATXG N/A
  • AVG Volume (30 Days)
  • SLRX 316.4K
  • ATXG 1.1M
  • Earning Date
  • SLRX 11-13-2025
  • ATXG 11-13-2025
  • Dividend Yield
  • SLRX N/A
  • ATXG N/A
  • EPS Growth
  • SLRX N/A
  • ATXG N/A
  • EPS
  • SLRX N/A
  • ATXG N/A
  • Revenue
  • SLRX N/A
  • ATXG $4,310,835.00
  • Revenue This Year
  • SLRX N/A
  • ATXG N/A
  • Revenue Next Year
  • SLRX N/A
  • ATXG N/A
  • P/E Ratio
  • SLRX N/A
  • ATXG N/A
  • Revenue Growth
  • SLRX N/A
  • ATXG N/A
  • 52 Week Low
  • SLRX $3.64
  • ATXG $0.36
  • 52 Week High
  • SLRX $108.00
  • ATXG $1.86
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 50.63
  • ATXG 56.94
  • Support Level
  • SLRX $3.86
  • ATXG $0.90
  • Resistance Level
  • SLRX $4.58
  • ATXG $1.08
  • Average True Range (ATR)
  • SLRX 0.37
  • ATXG 0.11
  • MACD
  • SLRX -0.14
  • ATXG -0.02
  • Stochastic Oscillator
  • SLRX 45.45
  • ATXG 45.65

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: